TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03723525

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Standard HIV care
Description: Standard of HIV care includes screening and management of OI (OI- tuberculosis (TB), bacterial pneumonia, herpes, and candidiasis), baseline assessment (CD4 and other blood tests- complete blood count, hemoglobin, platelets, liver function test, renal function test, urine for albumin, chest x-ray), at 6 months CD4 test, viral load (twice a year) and then on a yearly basis, additional lab test at 3 months, 6 months, antiretroviral (ARV) toxicity monitoring like hemoglobin (Zidovudine), Serum Glutamic-Pyruvic Transaminase (Nevirapine/Efavirenz), Creatinine (Tenofovir), prophylaxis (Co-trimoxazole preventive therapy CD4\<350 and WHO stage III and IV and Isoniazid preventive therapy if eligible) and ART / follow up (generally monthly/ bimonthly).
Study: NCT04165902

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: compare the effects of steroid plus hyaluronic acid and destrose plus hyaluronic acid on knee osteroarthritis
Description: compare the immediate effect (one week after 3 times of injections), short-term effects (one month and three months after 3 times of injections), and midterm effect (6 months after 3 times of injections).
Study: NCT02200393

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Abdominal FES
Description: Stimulation intensity was adjusted on a channel by channel basis until a strong visible contraction of the abdominal muscles is observed. During the session, manual adjustment of both the stimulation intensity (to compensate for fatigue) and the duty cycle is possible.~Four pairs of surface electrodes were placed on the participant's abdomen. One pair will be placed on both the right and left side of the rectus abdominis around the naval. One pair of electrodes will also be placed on both the right and left side of the external oblique muscles with one electrode being placed just below the participant's bottom rib and the other below this with a separation of around 3cm.
Study: NCT04165902

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: compare the effects of steroid plus hyaluronic acid and destrose plus hyaluronic acid on knee osteroarthritis
Description: compare the immediate effect (one week after 3 times of injections), short-term effects (one month and three months after 3 times of injections), and midterm effect (6 months after 3 times of injections).
Study: NCT04558853

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: autologous NK cells
Description: Autologous ex vivo expanded and activated NK cells
Study: NCT03863392

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: induction of labor

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Misoprostol
Description: induction of labor
Study: NCT00770185

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ridaforolimus
Description: oral ridaforolimus 40 mg days 1-5 each week (once daily for 5 consecutive days every week; cycle arbitrarily defined as a 4 week period)

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: gene expression analysis
Study: NCT01778231

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutrof Total
Description: Antioxidant and trace element supplement

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study: NCT04207684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone injection
Description: 250 mg of testosterone cypionate (equivalent to 174,8 mg of testosterone) administered via intramuscular injection in a single dose (2 mL)
Study: NCT01804634

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: preparative regimen

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: low dose total body irradiation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Study: NCT02308501

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lastacaft ®

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tears Naturale ® (Placebo)
Study: NCT01190033

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Neurotome OFF
Description: In this intervention the neurotome will be unconnected.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: neurolysis
Description: In this procedure the neurotome will be connected
Study: NCT00068666

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study: NCT04033991

Intervention type: DRUG
Intervention: Sunitinib
Description: Tyrosine kinase inhibitor, licensed for use in treatment of renal cell carcinoma.

Intervention type: DRUG
Intervention: Axitinib
Description: Tyrosine kinase inhibitor, licensed for use in treatment of renal cell carcinoma.
Study: NCT00967863

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-dimensional conformal radiation therapy
Description: Patients undergo radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-dimensional conformal radiation therapy
Description: Patients undergo radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: Patients undergo radiotherapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: intensity-modulated radiation therapy
Description: Patients undergo radiotherapy
Study: NCT01324466

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NB-001
Description: Topical, 5 times daily until investigator assessment of healing or a maximum of 4 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vehicle
Description: Topical, 5 times daily until investigator assessment of healing or a maximum of 4 days
Study: NCT03765359

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metforminhydrochloride
Description: metformin 500 mg tablets and insulin
Study: NCT01470378

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Thigh Surgery
Description: Circumferential thigh surgery post bariatric surgery
Study: NCT00770185

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: immunohistochemistry staining method

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Study: NCT02410161

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: alpha-linolenic acid-rich supplement
Description: each participant consumed one 1000 mg capsule of flaxseed oil four times per day for 4 weeks, providing a total of 2 g/d of ALA. The capsules used were a commercially available flaxseed oil supplement containing ALA at 56% of total fatty acids (Jamieson, Toronto, ON, Canada). The other main fatty acids present in flaxseed oil include linoleic acid (18%), oleic acid (16%), palmitic and stearic acid (10% combined).
Study: NCT04501458

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training of youth, community health assistants and community health workers.
Description: Training of youth, community health assistants, and community health workers in the screening, detection, contact tracing, prevention, and management of COVID-19 with concurrent maintenance of essential health services.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training clinicians in basic critical care and the management of severe COVID-19 cases
Description: Training clinicians in basic critical care and the management of severe COVID-19 cases with concurrent maintenance of essential health services.
Study: NCT02327910

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TOF unit TcPCO2 group
Description: The patients of U group were extubated when TOF ratio greater than 0.9 and TcPCO2 recovery to preoprative(±5mmHg)
Study: NCT03765359

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Oral Tablet
Description: Placebo tablets mimic metformin 500 mg tablets and insulin
Study: NCT00666978

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: smoking cessation intervention
Study: NCT02327910

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TOF group
Description: The patients of T group were extubated when TOF ratio greater than 0.9.
Study: NCT01198925

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: piperacillin continuous infusion
Description: piperacillin continuous infusion

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: piperacillin extended infusion
Description: piperacillin extended infusion
Study: NCT00632528

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MEOPA
Description: Administration of MEOPA gaz during postoperative physical therapy

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Medicinal air
Description: Administration of medical air during postoperative physical therapy
Study: NCT04635787

Intervention type: DEVICE
Intervention: ANNE One
Description: Wireless vital sign monitoring device

Intervention type: DEVICE
Intervention: ANNE One
Description: Wireless vital sign monitoring device
Study: NCT00131911

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib tosylate
Description: 400 mg given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib tosylate
Description: 400 mg given orally
Study: NCT01913964

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetylcarnitine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: (sugar pill)
Study: NCT02877953

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: the prevention of complications post-TIPS
Description: Continuous nursing through telephone follow-up, family visits, and WeChat guided patients to prevent gastrointestinal bleeding, infection and constipation ,intake quality low-protein diet, recognize minimal encephalopathy, monitor blood ammonia, return visit regularly, deal with adverse drug reactions of anticoagulant.
Study: NCT03519581

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Micropulse Laser Treatment
Description: Participant's study eye will be dilated prior to being comfortably seated at the slit lamp for treatment. Application of micropulse laser on retinal surface will occur using TxCell Scanning Delivery System in a 7 x 7 grid to surround the fovea.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham Treatment
Description: Participant's study eye will be dilated prior to being comfortably seated at the slit lamp for treatment. No actual laser treatment will occur.
Study: NCT03666065

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspart insulin
Description: Standard insulin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aspart insulin
Description: Standard insulin
Study: NCT04219709

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Very low carbohydrate diet
Description: All meals will be delivered and participants will consume study foods exclusively. Participants will receive a fiber supplement with each meal as needed to promote digestive health, and a daily multi-vitamin, magnesium and omega-3 supplement to ascertain micronutrient sufficiency. Participants will be weighed at each study visit and the diet plan will be adjusted for satiety and weight-maintenance.~The diet composition will be as follows: 5% carbohydrate, 75% fat, 20% protein.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard carbohydrate diet
Description: All meals will be delivered and participants will consume study foods exclusively. Participants will receive a daily multi-vitamin and omega-3 supplement to ascertain micronutrient sufficiency. Participants will be weighed at each study visit and the diet plan will be adjusted for satiety and weight-maintenance.~The diet composition will be as follows: 50% carbohydrate, 30% fat, 20% protein.
Study: NCT04179994

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Miswak extract-containing toothpaste
Description: Miswak extract-containing toothpaste will be applied to the tooth diagnosed with DH

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Potassium nitrates-containing toothpaste
Description: Potassium nitrates-containing toothpaste will be applied to the tooth diagnosed with DH

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A toothpaste containing the same ingredients of the test toothpaste except for the active ingredient
Study: NCT00401921

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Minocycline
Description: 100 mg, 1 capsule PO BID starting 36 hours prior to surgery. 2 capsules the morning of surgery

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: 1 capsule PO BID starting 36 hours prior to surgery. 2 capsules the morning of surgery.
Study: NCT04676828

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Single-photon-emission CT scan
Description: SPECT/CT scan is an established functional modality used in the diagnosis and monitoring of lung disease. SPECT/CT scan images pulmonary circulation, where perfused areas equate with normal functional lung
Study: NCT00620958

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individual cognitive behavioral therapy (ICBT)
Description: ICBT will include 12 to 14 sessions during which child participants will learn how to change anxious and fearful thoughts and to deal with feared objects and events.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent relationship training (PRT2) With Individual Cognitive Behavioral Therapy (ICBT)
Description: Parent relationship training will teach the parent ways to communicate with the child and to solve problems to help discourage child avoidant behaviors. ICBT will include 12 to 14 sessions during which child participants will learn how to change anxious and fearful thoughts and to deal with feared objects and events.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent reinforcement training (PRT1) With Individual Cognitive Behavioral Therapy (ICBT)
Description: Parent reinforcement training will teach the parent strategies for managing the child's behavior through the use of positive rewards and positive parental behaviors to help discourage child avoidant behaviors. ICBT will include 12 to 14 sessions during which child participants will learn how to change anxious and fearful thoughts and to deal with feared objects and events.
Study: NCT00496990

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced care
Description: this group received counseling, contingency management and methadone or detoxification

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: this group receives the opportunity to participate in a support group
Study: NCT01472432

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo is added to the standard good medical practice. Plus Metformin and/or Sulfonylurea

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vildagliptin
Description: 50 mg per os b.i.d. for 4 months of treatment, added to the standard good medical practice.Plus Metformin and/or Sulfonylurea
Study: NCT01275664

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjuvant Therapy
Description: Ancillary studies
Study: NCT00666978

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: smoking cessation intervention

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bupropion hydrochloride

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: gene expression analysis

Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: gene expression analysis

Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: polymerase chain reaction

Intervention type: GENETIC
Group type: PLACEBO_COMPARATOR
Intervention: polymerase chain reaction

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: counseling intervention

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: counseling intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: educational intervention

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: educational intervention

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: psychosocial assessment and care

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: psychosocial assessment and care
Study: NCT02884466

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation intervention
Description: Both groups will receive examination and medicine adjustment from a rheumatologist, and treatment from physiotherapist, occupational therapist and nursing staff, respectively. The multidisciplinary rehabilitation intervention in both groups will be based on the biopsychosocial model of illness. The inpatient stays of 8-10 hours per day will consist of 1) group tuition, 2) group and individual treatment and 3) unassisted training sessions.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Multidisciplinary rehabilitation intervention
Description: Both groups will receive examination and medicine adjustment from a rheumatologist, and treatment from physiotherapist, occupational therapist and nursing staff, respectively. The multidisciplinary rehabilitation intervention in both groups will be based on the biopsychosocial model of illness. The inpatient stays of 8-10 hours per day will consist of 1) group tuition, 2) group and individual treatment and 3) unassisted training sessions.
Study: NCT01203462

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Probiotic strain of Bifidobacterium
Description: 4 ounces (113g) of yogurt per day, for 14 days. Minimum Bifidobacterium dose of 1E+10 cfu/serving.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: No Bifidobacterium
Description: 4 ounces (113g) of yogurt per day, for 14 days. No bifidobacterium added.
Study: NCT04442620

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical activity and Mediterranean Diet (PA-MD)
Description: Physical Activity plus caloric restricted Mediterranean diet

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High meal frequency of Mediterranean Diet (HMF-MD)
Description: High meal frequency of unaltered Mediterranean diet

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control diet (CD)
Description: Control Diet
Study: NCT00388362

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sirolimus
Description: Patients will receive sirolimus at 2 mg/day orally with monitoring of trough drug levels weekly for 2 weeks to achieve trough drug levels 7-12 ng/ml. Along with prednisone therapy.
Study: NCT00520689

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Silicone Hydrogel Contact Lens
Description: use of lens over 2 days

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Silicone Hydrogel Contact Lens
Description: use of lens over 2 days

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Silicone Hydrogel Contact Lens
Description: use of lens over 2 days

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Silicone Hydrogel Contact Lens
Description: use of lens over 2 days
Study: NCT01477632

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.5 mg estradiol / 0.1 mg norethisterone acetate (NETA)
Description: A single oral dose of 2 tablets under fasting conditions

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 0.5 mg estradiol / 0.25 mg norethisterone acetate (NETA)
Description: A single oral dose of 2 tablets under fasting conditions

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)
Description: A single oral dose of 1 tablet under fasting conditions
Study: NCT01571674

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Manipulation + Exercise Group
Description: First 2 sessions~* High-velocity, low-amplitude manipulations to the thoracic spine.~* Low-velocity mid to end-range mobilizations to the cervical spine.~* Active Range of Motion Exercises for the cervicothoracic spine~Final 6 sessions~◦ Evidence based shoulder girdle exercise program

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Group
Description: First 2 sessions~◦ Active Range of Motion Exercises for the cervicothoracic spine~Final 6 sessions~◦ Evidence based shoulder girdle exercise program

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Exercise Group
Description: First 2 sessions~◦ Active Range of Motion Exercises for the cervicothoracic spine~Final 6 sessions~◦ Evidence based shoulder girdle exercise program
Study: NCT01469923

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: AZD2820
Description: Ascending subcutaneous injections of AZD2820 once daily for 14 days in the abdomen

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Ascending subcutaneous injections of placebo for AZD2820 once daily for 14 days in the abdomen
Study: NCT04507308

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Single-session sleep intervention drawn from principles of the TranS-C youth protocol
Description: We are providing participants psychoeducation on sleep and will be going over several handouts from the Youth version of the Transdiagnostic Sleep and Circadian Intervention (TranS-C-Youth) to improve sleep.
Study: NCT01099826

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tailored counseling
Description: education tailored to baseline beliefs by trained counselor over phone

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interview
Description: motivational interview by trained MI counselors by phone
Study: NCT02847611

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamometer LABIN
Description: LABIN is a prototype of dynamometer containing a handle of metal strength, connected with a sensor of pressure registering(recording) the applied strength and transmitting the data in a computer showing an IT curve of the strength according to time.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynamometer LABIN
Description: LABIN is a prototype of dynamometer containing a handle of metal strength, connected with a sensor of pressure registering(recording) the applied strength and transmitting the data in a computer showing an IT curve of the strength according to time.